Access to medicine

We strive to make our medicines accessible to every patient who needs them. At taiba, we have long-standing experience with Named Patient Sales (NPS) programs in the Middle East.

Expanded access is also a priority for taiba, and we have been facilitating compassionate use of niche medicines for patients with life-threatening and orphan diseases such as cystic fibrosis, Paroxysmal nocturnal hemoglobinuria (PNH) and primary hyperoxaluria type 1 (PH1)